December 8, 2022
Following five key Buddhist teachings may help protect against depression, new research shows. A study from Thailand showed that among people who observed what are known […]
December 7, 2022
The push to legalize psychedelic drugs is gaining momentum in states across the country, with a sevenfold increase in the number of decriminalization bills since 2019, […]
December 6, 2022
A brief aerobic exercise intervention can augment the benefits of exposure therapy for posttraumatic stress disorder (PTSD), new research suggests. Investigators randomly assigned individuals with PTSD […]
December 5, 2022
SAN FRANCISCO — In a widely anticipated report, researchers reported that a phase 3 study showed statistically significant improvements in patients with agitation related to Alzheimer’s […]
December 5, 2022
SAN FRANCISCO — A multidomain intervention that includes counseling by health coaches is associated with “modest” improvements in cognition in older adults who have at least […]
December 2, 2022
A new study supports the hypothesis that changes in levels of amyloid and tau occur many years before the emergence of clinical symptoms of Alzheimer’s disease […]
December 2, 2022
As fentanyl-related overdose deaths continue to increase, clinicians should take note of important differences that set the drug apart from the other drugs of misuse — […]
December 1, 2022
SAN FRANCISCO ― A drug designed to harness tau tangles produced in Alzheimer’s disease (AD) failed to reach its primary endpoints of change in cognition and […]
November 30, 2022
SAN FRANCISCO — Widely anticipated data from a phase 3 trial of the monoclonal antibody lecanemab suggest the drug “modestly” relieved cognitive impairment in patients with […]